000 01212 a2200337 4500
005 20250518001331.0
264 0 _c20191213
008 201912s 0 0 eng d
022 _a1365-2133
024 7 _a10.1111/bjd.17255
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aNikkels, A
245 0 0 _aShould we provide anti-human papillomavirus vaccination for patients with genital hidradenitis suppurativa?
_h[electronic resource]
260 _bThe British journal of dermatology
_c01 2019
300 _a233 p.
_bdigital
500 _aPublication Type: Letter
650 0 4 _aCarcinoma
_xetiology
650 0 4 _aGenital Diseases, Male
_xcomplications
650 0 4 _aHidradenitis Suppurativa
_xcomplications
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aPapillomavirus Infections
_xetiology
650 0 4 _aPapillomavirus Vaccines
_xadministration & dosage
650 0 4 _aRisk Factors
650 0 4 _aSkin Neoplasms
_xetiology
650 0 4 _aSmoking
_xadverse effects
650 0 4 _aVaccination
_xmethods
700 1 _aLebas, E
773 0 _tThe British journal of dermatology
_gvol. 180
_gno. 1
_gp. 233
856 4 0 _uhttps://doi.org/10.1111/bjd.17255
_zAvailable from publisher's website
999 _c28884738
_d28884738